Tweet
VIVACELL-MTS SUPPORTS NATIONAL CENTER FOR ONCOLOGY IN GETTING STATE-OF-THE-ART FLUOROSCOPY AND RADIOGRAPHY DEVICE
13:26 13/03/2015 >> SOCIETY
VivaCell-MTS continues cooperating with the National Center for
Oncology after V. Fanarjyan. This year the center has acquired a
"Plessart VIVO" ("Toshiba", Japan) universal remote control digital
fluoroscopy and analog radiography comprehensive device. The company
has provided AMD 60 million for the acquisition of the equipment,
the press service of VivaCell-MTS reports.
"The Armenians often have to go abroad in order to undergo oncological
examinations and receive medical treatment. This has a negative effect
on the patient both from financial and psychological perspectives. The
reason for their decision is the lack of necessary equipment in
the Armenian medical centers: even highly qualified doctors need
state-of-the-art devices to carry out comprehensive examination of
the patient. I hope that the support VivaCell-MTS provides will add
to the efficiency of the doctors' efforts and will relieve the worries
of patients," VivaCell-MTS General Manager Ralph Yirikian commented.
Annually, the National Center for Oncology provides treatment to over
10,000 patients suffering various oncological diseases. Having a status
of a national center, the hospital provides medical assistance to the
whole country. 80 to 100 X-ray examinations (of lungs, osteo-muscular,
gastrointestinal systems and other) are carried out at the center
every day. The device used at the center till recently has been
in exploitation since the Soviet times. The introduction of the
newly obtained equipment will considerably increase the accuracy of
examinations and improve the results of the treatment.
VivaCell-MTS has been readily stretching hand to the National Center
for Oncology since 2010; as a result of the cooperation the center
has been refurbished with state-of-the-art devices. For this end,
the company has already made a total investment of more than AMD
178 million.
http://www.panorama.am/en/society/2015/03/13/viva-cell-mts/
From: A. Papazian
13:26 13/03/2015 >> SOCIETY
VivaCell-MTS continues cooperating with the National Center for
Oncology after V. Fanarjyan. This year the center has acquired a
"Plessart VIVO" ("Toshiba", Japan) universal remote control digital
fluoroscopy and analog radiography comprehensive device. The company
has provided AMD 60 million for the acquisition of the equipment,
the press service of VivaCell-MTS reports.
"The Armenians often have to go abroad in order to undergo oncological
examinations and receive medical treatment. This has a negative effect
on the patient both from financial and psychological perspectives. The
reason for their decision is the lack of necessary equipment in
the Armenian medical centers: even highly qualified doctors need
state-of-the-art devices to carry out comprehensive examination of
the patient. I hope that the support VivaCell-MTS provides will add
to the efficiency of the doctors' efforts and will relieve the worries
of patients," VivaCell-MTS General Manager Ralph Yirikian commented.
Annually, the National Center for Oncology provides treatment to over
10,000 patients suffering various oncological diseases. Having a status
of a national center, the hospital provides medical assistance to the
whole country. 80 to 100 X-ray examinations (of lungs, osteo-muscular,
gastrointestinal systems and other) are carried out at the center
every day. The device used at the center till recently has been
in exploitation since the Soviet times. The introduction of the
newly obtained equipment will considerably increase the accuracy of
examinations and improve the results of the treatment.
VivaCell-MTS has been readily stretching hand to the National Center
for Oncology since 2010; as a result of the cooperation the center
has been refurbished with state-of-the-art devices. For this end,
the company has already made a total investment of more than AMD
178 million.
http://www.panorama.am/en/society/2015/03/13/viva-cell-mts/
From: A. Papazian